Skip to content
My WebMD Sign In, Sign Up

Breast Cancer Health Center

Font Size

Drug May Be New Option to Cut Breast Cancer Risk

Study Shows Aromasin May Help Prevent Breast Cancer in High-Risk Women

Tracking Breast Cancer Risk continued...

The study wasn't able to show that the drug improved overall survival, however.

Adverse events were reported by 88% of women on Aromasin and 85% of women taking the placebo.

Arthritis and hot flashes were slightly more common in the treatment group.

There were no differences between the groups in the numbers of women who were newly diagnosed with osteoporosis or cardiovascular events.

Serious adverse events in the study were rare and none were judged to be attributable to Aromasin.

The study was sponsored by the Canadian Cancer Society Research Institute, the Canadian Institutes of Health Research, the Avon Foundation, and Pfizer, the company that makes Aromasin.


Today on WebMD

Breast Cancer Overview
From self-exams and biopsies to reconstruction, we’ve got you covered.
Dealing with breast cancer
Get answers to your questions.
woman having mammogram
Experts don’t agree on all fronts, but you can be your own advocate.
woman undergoing breast cancer test
Many women worry. But the truth? Most abnormalities aren’t breast cancer.
Breast Cancer Treatments Improving
Resolved To Quit Smoking
Woman getting mammogram
Screening Tests for Women
ovarian cancer overview slideshow
serious woman
what is your cancer risk
10 Ways to Revitalize Slideshow